drugset / Trial / NCT00550797
Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma
RandomizedCrossoverQuadruple-blindTreatment
Summary
The researchers propose to study the airways of asthmatics given TPI ASM8 for 14 days, and examine the protective effects on allergen-induced bronchoconstriction, hyperresponsiveness and airway inflammation.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-07
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TPI ASM8 | Oligonucleotide (other) | 1 mg | Inhaled |